搜尋結果
Could this advance in radionuclide therapy help late-stage cancer patients?
South China Morning Post· 12 小時前Peking University, whose researchers led the study along with researchers from Peking Union ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 1 日前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall ...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 1 日前There's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks ...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters· 3 日前, opens new tab experimental blood test for a cancer of colon or rectum may fail to detect some ...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 5 日前In 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was ...
See How This Company Uses AI To Decode Genomic Diversity
Forbes· 15 小時前Artificial intelligence (AI) has many applications and is, in most cases, indetectable. The ...
Biomed 2024 Showcases Israel’s Resilient Entrepreneurial Spirit
Forbes· 5 日前The need to defend Israeli citizens on multiple fronts for more than seven months has not ...
Microsoft Announces New Foundation Model For Digital Pathology, Diving Deeper Into Clinical Medicine
Forbes· 3 日前The process of transforming a standard microscopy slide of tumor tissue into a high-resolution ...
Council Post: Knowing When A Nonprofit Can Reach Further
Forbes· 15 小時前In 2007, I founded the Isabella Santos Foundation (ISF) in honor of my daughter, who was ...
U.S. FDA advisers back approval for Guardant's blood-based cancer test
Reuters· 22 小時前, opens new tab blood test to detect a cancer that begins in the colon or rectum. The panel ...